A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia

NCT01606436 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenic Disorders

Interventions

DRUG: LY2140023
DRUG: Placebo
DRUG: Moxifloxacin

Sponsor

Denovo Biopharma LLC